What to think, do and say about the Covid-19 vaccination?
Blog written by Jean-Hervé Bradol, director of studies at the Crash.
Today, in order to obtain supplies of vaccines against Covid-19, there is neither a major difficulty related to price, nor a major obstacle related to intellectual property rules, nor a deficit in bio-medical research. However, these three topics are generally at the heart of MSF's communication in the area of access to medical care for those in most need. Our discourse must therefore evolve.
With the emergence of worrying variants of the virus present in the early stages of the pandemic and, as a consequence, the need to vaccinate on a global scale as quickly as possible, the world is facing a double challenge: biological engineering and ultra-industrial production – “ultra” echoing the need to produce on a global scale in a short period of time.
What to think, do and say about the Covid-19 vaccination?
Blog written by Jean-Hervé Bradol, director of studies at the Crash.
Today, in order to obtain supplies of vaccines against Covid-19, there is neither a major difficulty related to price, nor a major obstacle related to intellectual property rules, nor a deficit in bio-medical research. However, these three topics are generally at the heart of MSF's communication in the area of access to medical care for those in most need. Our discourse must therefore evolve.
With the emergence of worrying variants of the virus present in the early stages of the pandemic and, as a consequence, the need to vaccinate on a global scale as quickly as possible, the world is facing a double challenge: biological engineering and ultra-industrial production – “ultra” echoing the need to produce on a global scale in a short period of time.
Should we discriminate in order to act? Profiling: a necessary but debated practice
In this article for the Humanitarian Practice Network, head of the Research Unit on Humanitarian Stakes and Practices (UREPH) for MSF Geneva Françoise Duroch and Crash director of studies Michaël Neuman discuss the implications and reasons behind the growing practice of staff profiling for MSF.
In October 2020, MSF organised a workshop in Dakar on staff profiling in operations in the Sahel. Profiling involves the selection of staff based on non-professional criteria, including nationality, skin colour, gender and religion. As such, it raises a number of ethical and practical concerns. As a result of profiling, US nationals have not been deployed in MSF operations in Colombia because of the risk of kidnapping, and Chadians and Rwandans have been excluded in the Central African Republic and eastern Democratic Republic of Congo respectively, because of regional conflicts. The use of profiling has increased in recent years in West Africa, as the threat of kidnapping of Westerners by radical jihadist groups has intensified.
A “partnership” experience, A guided reading of Che Guevara's diary in Congo
Operational partnerships between two organisations are a practical approach to humanitarian responses. MSF considers such partnerships when the objective it is pursuing in a country is similar to that of an existing national organisation, and when there is potential for synergy between these two entities. I would like to take a bit of a detour by looking at an experience that is in some ways similar: when Che Guevara tried to lead the revolution in Congo - Zaire by supporting the organisation of the guerrilla movement in the east of the country.
Afghanistan : Should MSF accept the risk of targeted killings?
The May 12th massacre at the MSF-supported maternity hospital in Dasht-e-Barchi (Afghanistan) raises, yet again, the question of our limits with regard to risk. What is an acceptable level of danger for humanitarian aid workers? How do we set limits? Why would MSF decide to leave Kabul but remain in Herat, for example, or leave Afghanistan but remain in Niger, Burkina Faso, Mali, or Somalia, where the teams also face extreme danger?
Communicating and convincing: a humanitarian perspective on the French response to the coronavirus epidemic
In this paper, the two authors examine certain aspects of the French response to the epidemic in the light of the experience of Médecins Sans Frontières (MSF) in that field, primarily with respect to the relationship between the actors of the response and the beneficiaries.